A
Aardvark Therapeutics, Inc. (AARD)
NMS – Real Time Price. Currency in USD
6.11
+0.39 (6.82%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
6.11
+0.39 (6.82%)
At close: May 12, 2026, 4:00 PM EDT
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Dvorit Samid Ph.D. | Executive Vice President of Medical Affairs |
| Dr. Manasi Sinha Jaiman M.D., M.P.H. | Chief Medical Officer |
| Dr. Tien-Li Lee M.D. | CEO, Secretary & Director |
| Dr. Timothy J. Kieffer Ph.D. | Chief Scientific Officer |
| Dr. Zhenhuan Zheng Ph.D. | Chief Research Officer |
| Mr. Christian Zapf J.D. | General Counsel |
| Mr. Danny Villeneuve | Chief Commercial Officer |
| Mr. Justin T. Stege Ph.D. | VP and Head of Project Management & Strategy |
| Mr. Nelson B. Sun M.B.A. | CFO & COO |
| Mr. Ron Lewis II, Ph.D. | VP & Head of CMC |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | ck0001774857-20260507.htm |
| 2026-05-07 | 10-Q | ck0001774857-20260331.htm |
| 2026-03-30 | CORRESP | filename1.htm |
| 2026-03-24 | S-8 | ck0001774857-20260323.htm |
| 2026-03-23 | S-3 | ck0001774857-20260323.htm |
| 2026-02-27 | 8-K | ck0001774857-20260227.htm |
| 2026-02-12 | 8-K | ck0001774857-20260209.htm |
| 2026-02-10 | 8-K | ck0001774857-20260210.htm |
| 2026-01-12 | 8-K | ck0001774857-20260112.htm |
| 2025-12-10 | 8-K | ck0001774857-20251210.htm |